Literature DB >> 11956897

[Acupuncture in the treatment of locomotive disorders - status of research and situation regarding clinical application].

A Molsberger1, G Böwing, M Haake, U Meier, J Winkler, F Molsberger.   

Abstract

Acupuncture has been used for over 2000 years for a wide variety of complaints with minimal side effects. Based on the experience in Chinese medicine and the anticipated positive effects, acupuncture has been widely accepted in Western medicine as well. Some clinical evidence supports the efficacy of acupuncture treatment, but randomized controlled trials have been conducted for only a few of all possible locomotive disorder indications, and the results have been equivocal. Other indications have not yet been systematically studied, and application is based on clinical experience and consensus among practitioners. One of the outcomes on which consensus appears to exist is that 10-20 sessions are generally necessary, and that initial improvement can be expected to occur by the 10th treatment. Rigorous trials should be conducted to improve clinical validity and provide scientific proof of the efficacy of acupuncture. Clinical trials like the German Acupuncture Trials (gerac), funded by the German health insurance companies, have been launched with the aim of furthering knowledge in this area.

Entities:  

Mesh:

Year:  2002        PMID: 11956897     DOI: 10.1007/s00482-002-0145-2

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  3 in total

Review 1.  [Arthrosis update].

Authors:  S Rehart; H Lehnert
Journal:  Z Rheumatol       Date:  2008-07       Impact factor: 1.372

2.  The practice of acupuncture: who are the providers and what do they do?

Authors:  Karen J Sherman; Daniel C Cherkin; David M Eisenberg; Janet Erro; Andrea Hrbek; Richard A Deyo
Journal:  Ann Fam Med       Date:  2005 Mar-Apr       Impact factor: 5.166

3.  [German Acupuncture Trials (gerac) address problems of methodology associated with acupuncture studies].

Authors:  H G Endres; M Zenz; C Schaub; A Molsberger; M Haake; K Streitberger; G Skipka; C Maier
Journal:  Schmerz       Date:  2005-06       Impact factor: 1.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.